10071099

Source:http://linkedlifedata.com/resource/pubmed/id/10071099

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0087111, umls-concept:C0205191, umls-concept:C0231174, umls-concept:C0235025, umls-concept:C0439858, umls-concept:C0871261, umls-concept:C1704632, umls-concept:C1706817, umls-concept:C2911692
pubmed:issue	2
pubmed:dateCreated	1999-4-13
pubmed:abstractText	The effect of interferon-beta1a (INF-beta1a; Rebif) was studied in patients with chronic motor neuropathies not improving after conventional treatments such as immunoglobulins, steroids, cyclophosphamide or plasma exchange.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/10071099-1745285, http://linkedlifedata.com/resource/pubmed/commentcorrection/10071099-1952828, http://linkedlifedata.com/resource/pubmed/commentcorrection/10071099-2211468, http://linkedlifedata.com/resource/pubmed/commentcorrection/10071099-2405291, http://linkedlifedata.com/resource/pubmed/commentcorrection/10071099-2843079, http://linkedlifedata.com/resource/pubmed/commentcorrection/10071099-3023444, http://linkedlifedata.com/resource/pubmed/commentcorrection/10071099-3363593, http://linkedlifedata.com/resource/pubmed/commentcorrection/10071099-7477976, http://linkedlifedata.com/resource/pubmed/commentcorrection/10071099-7529476, http://linkedlifedata.com/resource/pubmed/commentcorrection/10071099-7673950, http://linkedlifedata.com/resource/pubmed/commentcorrection/10071099-7745420, http://linkedlifedata.com/resource/pubmed/commentcorrection/10071099-7798127, http://linkedlifedata.com/resource/pubmed/commentcorrection/10071099-8360326, http://linkedlifedata.com/resource/pubmed/commentcorrection/10071099-8498806, http://linkedlifedata.com/resource/pubmed/commentcorrection/10071099-8773599, http://linkedlifedata.com/resource/pubmed/commentcorrection/10071099-8936360, http://linkedlifedata.com/resource/pubmed/commentcorrection/10071099-9007107, http://linkedlifedata.com/resource/pubmed/commentcorrection/10071099-9221964, http://linkedlifedata.com/resource/pubmed/commentcorrection/10071099-9352454, http://linkedlifedata.com/resource/pubmed/commentcorrection/10071099-9443462
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/2985191R
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Interferon-beta, http://linkedlifedata.com/resource/pubmed/chemical/interferon beta 1a
pubmed:status	MEDLINE
pubmed:month	Feb
pubmed:issn	0022-3050
pubmed:author	pubmed-author:MartinoI EIE, pubmed-author:MeulsteeJJ, pubmed-author:SchmitzP IPI, pubmed-author:van DoornP APA, pubmed-author:van der MechéF GFG
pubmed:issnType	Print
pubmed:volume	66
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	197-201
pubmed:dateRevised	2009-11-18
pubmed:meshHeading	pubmed-meshheading:10071099-Adult, pubmed-meshheading:10071099-Aged, pubmed-meshheading:10071099-Chronic Disease, pubmed-meshheading:10071099-Female, pubmed-meshheading:10071099-Humans, pubmed-meshheading:10071099-Interferon-beta, pubmed-meshheading:10071099-Male, pubmed-meshheading:10071099-Middle Aged, pubmed-meshheading:10071099-Motor Neuron Disease, pubmed-meshheading:10071099-Prospective Studies, pubmed-meshheading:10071099-Severity of Illness Index, pubmed-meshheading:10071099-Treatment Failure, pubmed-meshheading:10071099-Walking
pubmed:year	1999
pubmed:articleTitle	Chronic motor neuropathies: response to interferon-beta1a after failure of conventional therapies.
pubmed:affiliation	Department of Neurology, University Hospital Rotterdam, Dr Molewaterplein, The Netherlands.
pubmed:publicationType	Journal Article, Clinical Trial